Those are great, though they are pretty early results. I think in both cases, they finished giving the 2nd dose around February, so we've only had around 1 mont

Those are great, though they are pretty early results. I think in both cases, they finished giving the 2nd dose around February, so we've only had around 1 month of data. I'm a little confused by the percentage though. Looking at the 2nd study, and ignoring 1-7 days after the second dose, there's still 8+7 people who got infected a week after the 2nd dose, out of ~5000 tested. How do they get to the 0.05% number? Also, if I understand correctly, the table says there's around 16,000 eligible, but only 4000-5000 were tested? Am I missing something?